Dao-bin J. Zhou

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications

Clinical characteristics, genomic profiling, treatments, and outcomes of Langerhans cell sarcoma.

Clinical characteristics, genomic profiling, treatments, and outcomes of Langerhans cell sarcoma.

Journal: Orphanet journal of rare diseases
Published: August 24, 2025

A pulsar-helium star compact binary system formed by common envelope evolution.

A pulsar-helium star compact binary system formed by common envelope evolution.

Journal: Science (New York, N.Y.)
Published: May 22, 2025

Evidence of the modified staging system and comparative performance of IPSS and revised IPSS in a Single-Center Asian cohort with Waldenström macroglobulinemia.

Evidence of the modified staging system and comparative performance of IPSS and revised IPSS in a Single-Center Asian cohort with Waldenström macroglobulinemia.

Journal: Leukemia & lymphoma
Published: May 18, 2025

High resolution chest computed tomography responses for a cohort of adult with pulmonary Langerhans cell histiocytosis.

High resolution chest computed tomography responses for a cohort of adult with pulmonary Langerhans cell histiocytosis.

Journal: Annals of hematology
Published: September 14, 2024

Long-term follow-up of methotrexate and cytarabine in adult patients with Langerhans cell histiocytosis.

Long-term follow-up of methotrexate and cytarabine in adult patients with Langerhans cell histiocytosis.

Journal: British journal of haematology
Published: July 29, 2024

Clinical Spectrum and Outcome of Kidney Involvement in Non-Langerhans Histiocytosis.

Clinical Spectrum and Outcome of Kidney Involvement in Non-Langerhans Histiocytosis.

Journal: Kidney international reports
Published: July 20, 2024

BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes.

BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 12, 2024

Cardiac Response Dynamics in Newly Diagnosed Light-Chain Amyloidosis Patients With Early and High-Quality Hematologic Response.

Cardiac Response Dynamics in Newly Diagnosed Light-Chain Amyloidosis Patients With Early and High-Quality Hematologic Response.

Journal: JACC. Asia
Published: April 24, 2024

Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 study.

Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 study.

Journal: EClinicalMedicine
Published: March 18, 2024

Liver involvement with Langerhans cell histiocytosis in adults.

Liver involvement with Langerhans cell histiocytosis in adults.

Journal: The oncologist
Published: March 11, 2024

Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study.

Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study.

Journal: Haematologica
Published: February 03, 2024

Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia.

Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia.

Journal: Annals of hematology
Published: December 17, 2023
Showing 1-12 of 142

Last Updated: 09/26/2026